Building a picture of inflammatory arthritis in cystic fibrosis

Identifying a Phenotype in Cystic Fibrosis Associated Arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN34533467

Enrollment

Registered

2017-09-11

Start date

2017-10-14

Completion date

Unknown

Last updated

2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis Associated Arthropathy Musculoskeletal Diseases Cystic Fibrosis Associated Arthropathy

Interventions

This is an observational study looking at cystic fibrosis associated arthropathy patterns of disease, to include clinical history and examination, serology, and ultrasound. Patients with CF who have

urate (for gout)

rheumatoid factor and anti CCP (associated with rheumatoid arthritis) and HLA-B27 (associated with seronegative spondyloarthropathies). Participants are then seen as and when their joint symptoms fl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cystic Fibrosis 2. Peripheral joint disease including current or previous joint swelling affecting activities of daily living 3. Aged over 16 4. Attendance at either the Manchester or Leeds CF centre

Exclusion criteria

Exclusion criteria: 1. Joint problems that when reviewed sound primarily biomechanical or have another non-inflammatory cause 2. Under 16 years

Design outcomes

Primary

Measure	Time frame
Patterns of disease identified by clinical manifestation, ultrasound findings and serology over a 9 month follow-up.	—

Secondary

Measure	Time frame
There are no secondary outcome measures.	—

Countries

United Kingdom

Contacts

Public ContactElizabeth Clarke

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026